Laura Bae

Laura Bae is the Chief Executive Officer of Silver Spur Therapeutics, where she leads the company’s strategy, operations, and capital formation efforts to advance a next-generation precision nanomedicine platform targeting serious renal and cardiovascular diseases. Laura brings deep experience building and scaling early-stage companies, with a strong track record in company formation, strategic planning, fundraising, and operational execution. She has founded and led multiple ventures, working closely with scientific, technical, and commercial teams to translate complex innovation into clear narratives and executable development plans. At Silver Spur Therapeutics, Laura focuses on bridging science and strategy — guiding preclinical development, shaping regulatory and translational pathways, and building partnerships that position the company for long-term value creation. She is particularly experienced in early-stage fundraising, investor communications, and structuring organizations for scale while maintaining disciplined capital allocation.